MI
ABBV icon

Motiv8 Investments’s AbbVie ABBV Stock Holding History

Motiv8 Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.69M Sell
7,387
-1,730
-19% -$394K 0.92% 28
2025
Q3 		$2.11M Buy
9,117
+1,197
+15% +$244K 1.12% 25
2025
Q2 		$1.47M Buy
7,920
+684
+9% +$127K 0.9% 39
2025
Q1 		$1.52M Buy
7,236
+342
+5% +$66.5K 1.01% 28
2024
Q4 		$1.23M Buy
6,894
+1,395
+25% +$256K 0.86% 34
2024
Q3 		$1.09M Buy
5,499
+577
+12% +$108K 0.73% 31
2024
Q2 		$845K Buy
4,922
+120
+2% +$19.9K 0.63% 41
2024
Q1 		$874K Buy
4,802
+507
+12% +$87.4K 0.68% 32
2023
Q4 		$666K Buy
+4,295
New +$626K 0.59% 35

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Motiv8 Investments's ABBV Position: Q4 2025 in Review

Motiv8 Investments reduced its AbbVie (ABBV) stake by 19% in Q4 2025, selling an estimated $394K and leaving 7,387 shares worth $1.69M. The position accounts for 0.92% of the portfolio, ranked #28.

Motiv8 Investments first reported a position in ABBV in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.11M in Q3 2025. 4,158 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Motiv8 Investments held 7,387 shares of AbbVie worth $1.69M as of Q4 2025.
  • Motiv8 Investments sold 1,730 AbbVie shares in Q4 2025, an estimated $394K.
  • AbbVie made up 0.92% of Motiv8 Investments's portfolio in Q4 2025, its #28 holding.
  • Motiv8 Investments first reported a position in AbbVie in Q4 2023 and has held it in 9 quarters since.
  • Motiv8 Investments's AbbVie position peaked at $2.11M in Q3 2025.
  • 4,158 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.